IPHA APPOINTS NEW DIRECTOR OF COMMERCIAL POLICY
11 March 2020
The Irish Pharmaceutical Healthcare Association (IPHA) has today announced the appointment of Jim McGrath to the role of Director of Commercial Policy.
Mr. McGrath has spent the last three years as Public Affairs Director with the corporate advisory firm Teneo, where he has provided policymaking and strategic support to many of Ireland’s leading businesses including in the healthcare and pharmaceutical sectors.
Mr. McGrath also has over eight years senior-level policymaking experience having previously been advisor across three separate Government departments – the Department of Business, Enterprise and Innovation, the Department of Environment and the Department of Transport. He also worked as an adviser in the European Parliament and is a former journalist.
IPHA Chief Executive Officer, Oliver O’Connor said:
“We are delighted to welcome Jim to IPHA and look forward to this new chapter for our organisation. This is a critical role for IPHA to build collaborative policy solutions with the State’s health authorities, so that the public in Ireland would have reliable, timely access to new medicines and technologies. An immediate priority is work on a new Agreement to achieve that goal.”
We are confident his experience and policymaking acumen will be of great benefit to the sector.”
Jim McGrath said:
“I am honoured to have been appointed to this key role, at a time of great change and challenge for the Irish pharma industry. Issues that we as a society face in terms of the future of healthcare – such as securing access to life-saving and life-enhancing medication – are central to the future well-being and welfare of Irish society. I’m enthusiastic to assist the industry respond to these challenges and improve the quality of healthcare available to all in Ireland.”
Mr McGrath will be taking up the role in early April.
Ends
*Headshot on request*
Jim McGrath Bio: on request
